Estrogen inhibits Dlk1/FA1 production: A potential mechanism for estrogen effects on bone turnover

Journal of Bone and Mineral Research

Volumn 26, Issue 10, 2011, Pages 2548-2551

  Abdallah, Basem M ^a,b   Bay Jensen, Anne Christine ^c   Srinivasan, Bhuma ^d   Tabassi, Nadine C ^e   Garnero, Patrick ^f   Delaissé, Jean Marie ^c   Khosla, Sundeep ^d   Kassem, Moustapha ^a,f  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Helwan University   (Egypt)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d MAYO CLINIC   (United States)

^e Synarc ^*  (France)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

bone turnover; Dlk1; estrogen; FA1; PREF 1

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; ESTROGEN; MEMBRANE PROTEIN; MEMBRANE PROTEIN DLK1; MEMBRANE PROTEIN FA1; OSTEOCALCIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN BLOOD LEVEL;

BONE REMODELING; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MIDDLE AGED;

EID: 80053194786     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.444     Document Type: Article

References (24)

1. Riggs BL, Khosla S, Melton L,. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002; 23: 279-302. (Pubitemid 34651948)
2. Pacifici R,. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996; 11: 1043-51. (Pubitemid 26321353)
3. Smas CM, Sul HS,. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell. 1993; 73: 725-34. (Pubitemid 23159011)
4. Wang Y, Sul HS,. Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor α-converting enzyme (TACE) and inhibition of adipocyte differentiation. Mol Cell Biol. 2006; 26: 5421-35. (Pubitemid 44036210)
5. Lee K, Villena JA, Moon YS, Kim KH, Lee S, Kang C, Sul HS,. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor 1 (Pref-1). J Clin Invest. 2003; 111: 453-61. (Pubitemid 36228002)
6. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ, Sul HS,. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol. 2002; 22: 5585-92. (Pubitemid 34755767)
7. Abdallah BM, Ditzel N, Mahmood A, Isa A, Traustadottir GA, Schilling AF, Ruiz-Hidalgo M, Laborda J, Amling M, Kassem M,. DLK1 is a novel regulator of bone mass that mediates estrogen-deficiency induced bone loss in mice. J Bone Miner Res. 2011; 26: 1457-71.
8. Kotzot D,. Abnormal phenotypes in uniparental disomy (UPD): fundamental aspects and a critical review with bibliography of UPD other than 15. Am J Med Genet. 1999; 82: 265-74. (Pubitemid 29078817)
9. Berends MJ, Hordijk R, Scheffer H, Oosterwijk JC, Halley DJ, Sorgedrager N,. Two cases of maternal uniparental disomy 14 with a phenotype overlapping with the Prader-Willi phenotype. Am J Med Genet. 1999; 84: 76-9. (Pubitemid 29169240)
10. Kurosawa K, Sasaki H, Sato Y, Yamanaka M, Shimizu M, Ito Y, Okuyama T, Matsuo M, Imaizumi K, Kuroki Y, Nishimura G,. Paternal UPD14 is responsible for a distinctive malformation complex. Am J Med Genet. 2002; 110: 268-72. (Pubitemid 34627632)
11. Abdallah BM, Ding M, Jensen CH, Ditzel N, Flyvbjerg A, Jensen TG, Dagnaes-Hansen F, Gasser JA, Kassem M,. Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. Endocrinology. 2007; 148: 3111-21. (Pubitemid 46996977)
12. Riggs BL, Melton IL III, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, Rouleau PA, McCollough CH, Bouxsein ML, Khosla S,. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004; 19: 1945-54. (Pubitemid 41103408)
13. Jensen CH, Krogh TN, Hojrup P, Clausen PP, Skjodt K, Larsson LI, Enghild JJ, Teisner B,. Protein structure of fetal antigen 1 (FA1): a novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2. Eur J Biochem. 1994; 225: 83-92. (Pubitemid 24306230)
14. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C,. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem. 1994; 40: 2022-5. (Pubitemid 24346167)
15. Price PA, Parthemore JG, Deftos LJ,. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest. 1980; 66: 878-83. (Pubitemid 11233785)
16. Jensen CH, Krogh TN, Stoving RK, Holmskov U, Teisner B,. Fetal antigen 1 (FA1), a circulating member of the epidermal growth factor (EGF) superfamily: ELISA development, physiology and metabolism in relation to renal function. Clin Chim Acta. 1997; 268: 1-20. (Pubitemid 28066798)
17. Bauer M, Szulc J, Meyer M, Jensen CH, Terki TA, Meixner A, Kinkl N, Gasser T, Aebischer P, Ueffing M,. Delta-like 1 participates in the specification of ventral midbrain progenitor derived dopaminergic neurons. J Neurochem. 2008; 104: 1101-15. (Pubitemid 351146578)
18. Jensen CH, Schroder HD, Teisner B, Laursen I, Brandrup F, Rasmussen HB,. Fetal antigen 1, a member of the epidermal growth factor superfamily, in neurofibromas and serum from patients with neurofibromatosis type 1. Br J Dermatol. 1999; 140: 1054-9. (Pubitemid 29284576)
19. Harken JC, Drivsholm L, Laursen I, Teisner B,. Elevated serum levels of fetal antigen 1, a member of the epidermal growth factor superfamily, in patients with small cell lung cancer. Tumour Biol. 1999; 20: 256-62. (Pubitemid 29356617)
20. Fazeli PK, Bredella MA, Misra M, Meenaghan E, Rosen CJ, Clemmons DR, Breggia A, Miller KK, Klibanski A,. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab. 2010; 95: 407-13.
21. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB,. Tissue distribution of estrogen receptors alpha (ER-α) and beta (ER-β) mRNA in the midgestational human fetus. J Clin Endocrinol Metab. 1997; 82: 3509-12. (Pubitemid 27419113)
22. Laborda J,. The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol Histopathol. 2000; 15: 119-29. (Pubitemid 30044297)
23. Moe KE, Prinz PN, Larsen LH, Vitiello MV, Reed SO, Merriam GR,. Growth hormone in postmenopausal women after long-term oral estrogen replacement therapy. J Gerontol A Biol Sci Med Sci. 1998; 53: B117-24. (Pubitemid 28136139)
24. Andersen M, Jensen CH, Stoving RK, Larsen JB, Schroder HD, Teisner B, Hagen C,. Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels. J Clin Endocrinol Metab. 2001; 86: 5465-70. (Pubitemid 33070276)